Xu Luo

11.6k total citations · 4 hit papers
67 papers, 9.3k citations indexed

About

Xu Luo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xu Luo has authored 67 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 12 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Xu Luo's work include Cell death mechanisms and regulation (21 papers), RNA Interference and Gene Delivery (8 papers) and MicroRNA in disease regulation (8 papers). Xu Luo is often cited by papers focused on Cell death mechanisms and regulation (21 papers), RNA Interference and Gene Delivery (8 papers) and MicroRNA in disease regulation (8 papers). Xu Luo collaborates with scholars based in United States, China and United Kingdom. Xu Luo's co-authors include Xiaodong Wang, I. Imawati Budihardjo, Hua Zou, George R. Oliver, Michael Lutter, M Sawadogo, Michèle Sawadogo, Peng Li, Xuesong Liu and William T. Garrard and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Xu Luo

66 papers receiving 9.2k citations

Hit Papers

Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Re... 1998 2026 2007 2016 1998 1999 2001 2024 500 1000 1.5k 2.0k 2.5k

Peers

Xu Luo
Deepak Nijhawan United States
Shile Huang United States
Atan Gross Israel
Paul G. Ekert Australia
Nika N. Danial United States
Ruth M. Kluck Australia
Deepak Nijhawan United States
Xu Luo
Citations per year, relative to Xu Luo Xu Luo (= 1×) peers Deepak Nijhawan

Countries citing papers authored by Xu Luo

Since Specialization
Citations

This map shows the geographic impact of Xu Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Luo more than expected).

Fields of papers citing papers by Xu Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Luo. The network helps show where Xu Luo may publish in the future.

Co-authorship network of co-authors of Xu Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Luo. A scholar is included among the top collaborators of Xu Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Luo. Xu Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Xu, Xue Gong, & Jianjun Xia. (2025). Assessment of the waste-to-energy potential for industrial steam supply and carbon emission reduction in Hainan, China. Renewable and Sustainable Energy Reviews. 217. 115749–115749. 2 indexed citations
2.
Tang, Xiao, Kun Wang, Xu Luo, et al.. (2024). Functional chitosan/HP-β-CD hydrogel for targeted co-delivery of Rhubarb-derived nanovesicles and kaempferol for alleviating ulcerative colitis. Carbohydrate Polymers. 352. 123206–123206. 7 indexed citations
3.
Zhou, Zhuan, Tasnim Arroum, Xu Luo, et al.. (2024). Diverse functions of cytochrome c in cell death and disease. Cell Death and Differentiation. 31(4). 387–404. 74 indexed citations breakdown →
4.
Cui, Miao, Xiaoyu Chen, Xu Luo, et al.. (2022). Dually stimulative single-chain polymeric nano lock with dynamic ligands for sensitive detection of circulating tumor cells. Biosensors and Bioelectronics. 217. 114692–114692. 5 indexed citations
5.
6.
Flores‐Romero, Hector, Marie‐Christine Albert, Louise King, et al.. (2021). BCL‐2‐family protein tBID can act as a BAX‐like effector of apoptosis. The EMBO Journal. 41(2). e108690–e108690. 127 indexed citations
7.
Blanco, Giovanny Rodriguez, David Sumpton, Catherine Cloix, et al.. (2020). Venetoclax causes metabolic reprogramming independent of BCL-2 inhibition. Cell Death and Disease. 11(8). 616–616. 69 indexed citations
8.
Luo, Xu, Lina Li, Wen Zheng, et al.. (2020). HLY78 protects blood-brain barrier integrity through Wnt/β-catenin signaling pathway following subarachnoid hemorrhage in rats. Brain Research Bulletin. 162. 107–114. 12 indexed citations
9.
Lee, Youngsun, Kalimuthu Kalishwaralal, Yong‐Seok Park, et al.. (2020). BAX-dependent mitochondrial pathway mediates the crosstalk between ferroptosis and apoptosis. APOPTOSIS. 25(9-10). 625–631. 81 indexed citations
10.
O’Neill, Katelyn, et al.. (2019). Retromer facilitates the localization of Bcl-xL to the mitochondrial outer membrane. Molecular Biology of the Cell. 30(10). 1138–1146. 20 indexed citations
11.
Beckett, Alison J., et al.. (2019). DRP-1 functions independently of mitochondrial structural perturbations to facilitate BH3 mimetic-mediated apoptosis. Cell Death Discovery. 5(1). 117–117. 23 indexed citations
12.
Zhang, Lei, et al.. (2019). Inhibition of JAK2/STAT3 signaling pathway protects mice from the DDP-induced acute kidney injury in lung cancer. Inflammation Research. 68(9). 751–760. 23 indexed citations
13.
Luo, Xu, et al.. (2018). Kinsenoside Ameliorates Oxidative Stress-Induced RPE Cell Apoptosis and Inhibits Angiogenesis via Erk/p38/NF-κB/VEGF Signaling. Frontiers in Pharmacology. 9. 240–240. 34 indexed citations
14.
Duan, Bensong, Jiangfeng Hu, Xu Luo, et al.. (2017). miRNA-338-3p/CDK4 signaling pathway suppressed hepatic stellate cell activation and proliferation. BMC Gastroenterology. 17(1). 12–12. 22 indexed citations
15.
Chen, Wei, Wenshu Zeng, Xu Luo, et al.. (2016). MicroRNA-155 promotes apoptosis in SKOV3, A2780, and primary cultured ovarian cancer cells. Tumor Biology. 37(7). 9289–9299. 25 indexed citations
16.
Shi, Hongxue, Cai Lin, Beibei Lin, et al.. (2013). The Anti-Scar Effects of Basic Fibroblast Growth Factor on the Wound Repair In Vitro and In Vivo. PLoS ONE. 8(4). e59966–e59966. 156 indexed citations
17.
Menezes, Miriam R., et al.. (2012). Pivotal Role of Inosine Triphosphate Pyrophosphatase in Maintaining Genome Stability and the Prevention of Apoptosis in Human Cells. PLoS ONE. 7(2). e32313–e32313. 34 indexed citations
18.
Cox, Jesse L., Sunil K. Mallanna, Xu Luo, & Angie Rizzino. (2010). Sox2 Uses Multiple Domains to Associate with Proteins Present in Sox2-Protein Complexes. PLoS ONE. 5(11). e15486–e15486. 49 indexed citations
19.
Cleland, Megan M., Kristi L. Norris, Mariusz Karbowski, et al.. (2010). Bcl-2 family interaction with the mitochondrial morphogenesis machinery. Cell Death and Differentiation. 18(2). 235–247. 90 indexed citations
20.
Qyang, Yibing, Xu Luo, Tao Lu, et al.. (1999). Cell-Type-Dependent Activity of the Ubiquitous Transcription Factor USF in Cellular Proliferation and Transcriptional Activation. Molecular and Cellular Biology. 19(2). 1508–1517. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026